Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay is a research paper published in Neuro-Oncology Advances (2021). On theSindex it has a DataRank of 1.0. It has been cited 26 times, with 24 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0.506
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 24 citers.
National Cancer Institute Small Business Innovation Research
Grant: HHSN261201400019C
National Cancer Institute
Grant: P30CA016056
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
FWCI
2.33
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals